Review: could Herceptin cause Heartburn - Chronic?


Heartburn - chronic is found among people who take Herceptin, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Paclitaxel, and have Breast cancer . We study 13,581 people who have side effects while taking Herceptin from FDA and social media. Among them, 10 have Heartburn - chronic. Find out below who they are, when they have Heartburn - chronic and more.

You are not alone

Join a support group for people who take Herceptin and have Heartburn - chronic >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Herceptin has active ingredients of trastuzumab. It is often used in breast cancer. (latest outcomes from Herceptin 13,715 users)

Heartburn - Chronic

Heartburn - chronic has been reported by people with breathing difficulty, diarrhea, insomnia, memory loss, fatigue (latest reports from 17,083 Heartburn - chronic patients).

On Aug, 25, 2016

13,581 people reported to have side effects when taking Herceptin.
Among them, 10 people (0.07%) have Heartburn - Chronic

Number of reports submitted per year:

Could Herceptin cause Heartburn - chronic?

Time on Herceptin when people have Heartburn - Chronic *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Heartburn - Chronic when taking Herceptin *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Heartburn - Chronic when taking Herceptin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 22.22 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 11.11 %

Top conditions involved for these people *:

  • Breast Cancer (7 people)
  • Neoplasm Malignant (1 person)
  • Metastases To Central Nervous System (1 person)
  • Breast Cancer Metastatic (1 person)

Top co-used drugs for these people *:

  • Paclitaxel (5 people)
  • Dexamethasone (3 people)
  • Cyclophosphamide (3 people)
  • Tarceva (2 people)
  • Doxorubicin Hcl (2 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Heartburn - chronic when taking Herceptin?

Browse all side effects of Herceptin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Heartburn - chronic

Heartburn - chronic

Could your condition cause Heartburn - chronic

Heartburn - chronic

Can you answer these questions?

More questions for: Herceptin, Heartburn - chronic

You may be interested in these reviews

More reviews for: Herceptin, Heartburn - chronic

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.